Genetically predicted TNF-beta protects against sarcopenia traits in humans
A Mendelian randomization analysis of 91 circulating inflammatory markers identified tumor necrosis factor-beta as causally linked to better muscle mass, grip strength, and walking pace.
Medicine · Mei Z et al. · Paper published 2 Oct 2026
In a human genetic study, researchers evaluated the causal links between circulating inflammatory factors and sarcopenia. The team performed a two-sample Mendelian randomization analysis testing 91 circulating inflammatory factors against four sarcopenia-related outcomes. Across these traits, tumor necrosis factor-beta emerged as a significant protective factor. Higher genetically predicted levels of the factor associated with increased appendicular lean mass, stronger left and right grip strength, and faster walking pace. These causal relationships held after Bonferroni correction and multiple sensitivity analyses. The authors concluded that circulating inflammatory pathways directly influence sarcopenia traits, highlighting tumor necrosis factor-beta as a potential target to inform future treatment strategies.
Why it matters
Loss of muscle mass and physical function is a central challenge in aging biology linked to chronic inflammation. Establishing a causal protective role for tumor necrosis factor-beta helps clarify how specific immune signaling pathways preserve musculoskeletal health in older age.
Caveats
The study relies on observational genetic data and Mendelian randomization rather than direct clinical interventions. The abstract does not report experimental validation of the biological mechanisms behind the observed protective effects.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
A Mendelian randomization study reveals TNF-β as a potential protective factor against sarcopenia
Mei Z, Wan Y, Mao X et al.
Medicine · 2 Oct 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Notable
- Evidence
- Humans
- Status
- Peer-reviewed
More on Inflammaging
See allCranial bone marrow monocytes drive brain injury inflammation and respond to fenofibrate
Targeting PPARα deficiency in cranial bone marrow monocytes improved cognitive function and reduced neurodegeneration markers in older patients with chronic brain injury.
Science translational medicine · Lu Z et al.
Somatic blood mutations associate with accelerated frailty and functional decline in humans
In a preprint analyzing over 730,000 adults, researchers linked clonal hematopoiesis to faster physical decline mediated by T-cell changes.
medRxiv · Zhao K et al.
Impaired glymphatic clearance links inflammation to accelerated brain aging in schizophrenia
Neuroimaging and post-mortem transcriptomics connect disrupted astrocytic aquaporin-4 polarization and blood-brain barrier breakdown to increased epigenetic and brain age.
bioRxiv · Tan X et al.
ASXL1 mutations in clonal hematopoiesis accelerate aortic valve calcification
Large human cohort data and cell experiments show that ASXL1-driven clonal hematopoiesis worsens aortic valve hemodynamics and promotes calcification through inflammatory signaling.
medRxiv · Small A et al.
Loss of SATB1 alters 3D genome architecture in aged mouse T cells
Declining levels of the chromatin organizer SATB1 disrupt genomic boundaries and drive inflammatory gene activation in naive CD4+ T cells.
Science advances · Wang B et al.